- Home
- SVRA vs FRPH Comparison
SVRA vs FRPH Comparison
Compare SVRA & FRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVRA
- FRPH
- Stock Information
- Founded
- SVRA 2007
- FRPH 1986
- Country
- SVRA United States
- FRPH United States
- Employees
- SVRA N/A
- FRPH N/A
- Industry
- SVRA Biotechnology: Pharmaceutical Preparations
- FRPH Real Estate
- Sector
- SVRA Health Care
- FRPH Finance
- Exchange
- SVRA Nasdaq
- FRPH Nasdaq
- Market Cap
- SVRA 527.2M
- FRPH 459.4M
- IPO Year
- SVRA N/A
- FRPH N/A
- Fundamental
- Price
- SVRA $3.61
- FRPH $25.27
- Analyst Decision
- SVRA Buy
- FRPH
- Analyst Count
- SVRA 8
- FRPH 0
- Target Price
- SVRA $6.63
- FRPH N/A
- AVG Volume (30 Days)
- SVRA 1.1M
- FRPH 59.0K
- Earning Date
- SVRA 11-11-2025
- FRPH 11-05-2025
- Dividend Yield
- SVRA N/A
- FRPH N/A
- EPS Growth
- SVRA N/A
- FRPH N/A
- EPS
- SVRA N/A
- FRPH 0.28
- Revenue
- SVRA N/A
- FRPH $32,293,999.00
- Revenue This Year
- SVRA N/A
- FRPH N/A
- Revenue Next Year
- SVRA N/A
- FRPH N/A
- P/E Ratio
- SVRA N/A
- FRPH $90.26
- Revenue Growth
- SVRA N/A
- FRPH 3.18
- 52 Week Low
- SVRA $1.89
- FRPH $23.52
- 52 Week High
- SVRA $4.30
- FRPH $33.00
- Technical
- Relative Strength Index (RSI)
- SVRA 60.48
- FRPH 56.18
- Support Level
- SVRA $3.35
- FRPH $24.57
- Resistance Level
- SVRA $3.75
- FRPH $25.28
- Average True Range (ATR)
- SVRA 0.13
- FRPH 0.49
- MACD
- SVRA -0.01
- FRPH 0.16
- Stochastic Oscillator
- SVRA 57.32
- FRPH 90.34
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.
About FRPH FRP Holdings Inc.
FRP Holdings Inc is a holding company engaged in various real estate businesses. The company's business segments are Leasing and management of commercial properties owned by the company (the Industrial/Commercial Segment); Leasing and management of mining royalty land owned by the company (the Mining Royalty Lands Segment); real property acquisition, entitlement, development and construction for apartment, retail, warehouse, and office buildings either alone or through joint ventures (the Development Segment); ownership, leasing and management of buildings through joint ventures (the Multifamily Segment).